CS Medica A/S Sustainability Profile
CS Medica A/S, headquartered in Denmark (DK), is a pioneering company in the medical device industry, specialising in innovative solutions for chronic pain management and respiratory care. Founded in 2015, CS Medica has rapidly established itself as a leader in the development of advanced medical technologies, focusing on non-invasive treatments that enhance patient quality of life. The company’s core offerings include cutting-edge devices for pain relief and respiratory support, distinguished by their user-friendly design and efficacy. With a commitment to research and development, CS Medica has achieved significant milestones, including numerous patents and certifications that underscore its dedication to safety and innovation. As a trusted name in the healthcare sector, CS Medica continues to expand its market presence, delivering unique solutions that meet the evolving needs of patients and healthcare professionals alike.
DitchCarbon Score
How does CS Medica A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CS Medica A/S's score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CS Medica A/S's reported carbon emissions
CS Medica A/S, headquartered in Denmark (DK), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that CS Medica A/S may not have established formal commitments to reduce carbon emissions or may be in the early stages of developing such initiatives. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability commitments to address climate change. However, without specific emissions data or reduction initiatives, it is unclear how CS Medica A/S aligns with these industry standards. As the company progresses, it may consider setting measurable targets to enhance its environmental impact and transparency.
How Carbon Intensive is CS Medica A/S's Industry?
How Carbon Intensive is CS Medica A/S's Location?
CS Medica A/S's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CS Medica A/S has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
